Medicare Enrolled

Dr. Richard Bryan, MD

Rheumatology · Queensbury, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
161 CAREY RD, Queensbury, NY 12804
5188248610
In practice since 2006 (19 years)
NPI: 1508952953 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bryan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bryan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bryan

Dr. Richard Bryan is a rheumatology specialist in Queensbury, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bryan performed 32,298 Medicare services across 1,008 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bryan received a total of $247,441 from 37 pharmaceutical and/or device companies across 977 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bryan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 10% volume in NY $247,441 industry payments

Medicare Practice Summary

Medicare Utilization ↗
32,298
Medicare services
Top 10% in NY for rheumatology
1,008
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,700 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
19,099 $10 $40
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
8,467 $26 $130
Denosumab injection (Prolia/Xgeva) 1,920 $18 $27
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
813 $90 $192
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
580 $1 $5
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
358 $22 $60
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
195 $97 $350
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
176 $1 $5
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
164 $49 $105
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
162 $7 $7
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
105 $53 $177
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
88 $119 $253
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
70 $6 $36
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
50 $11 $40
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
40 $10 $20
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
11 $47 $118
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
87.0% high complexity
9.7% medium
3.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$247,441
Total received (2018-2024)
Avg $35,349/year across 7 years
Top 3% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
977
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$234,065 (94.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,073 (4.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,303 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$30,957
2023
$24,155
2022
$24,426
2021
$23,788
2020
$23,086
2019
$61,366
2018
$59,664

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$28,261
ABBVIE INC.
$821
Janssen Biotech, Inc.
$438
AstraZeneca Pharmaceuticals LP
$375
GlaxoSmithKline, LLC.
$233
UCB, Inc.
$191
PFIZER INC.
$170
Janssen Scientific Affairs, LLC
$137
Amgen Inc.
$87
Novartis Pharmaceuticals Corporation
$67
Organon Llc
$58
Sandoz Inc.
$30
Teva Pharmaceuticals USA, Inc.
$25
SCILEX PHARMACEUTICALS INC.
$25
Fidia Pharma USA Inc.
$24
E.R. Squibb & Sons, L.L.C.
$17
Top 3 companies account for 95.4% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$109,165
Mallinckrodt Enterprises LLC
$42,580
Horizon Pharma plc
$26,055
Mallinckrodt LLC
$25,054
Horizon Therapeutics plc
$13,216
Genentech USA, Inc.
$11,709
Aurinia Pharma U.S., Inc.
$6,919
Janssen Biotech, Inc.
$3,261
AbbVie Inc.
$1,642
ABBVIE INC.
$1,443
AbbVie, Inc.
$1,374
PFIZER INC.
$1,048
AstraZeneca Pharmaceuticals LP
$696
UCB, Inc.
$615
GlaxoSmithKline, LLC.
$531
Amgen Inc.
$381
Novartis Pharmaceuticals Corporation
$356
E.R. Squibb & Sons, L.L.C.
$233
GENZYME CORPORATION
$225
Janssen Scientific Affairs, LLC
$210
Genentech, Inc.
$127
Organon LLC
$87
Lilly USA, LLC
$70
Exeltis, USA Inc.
$61
ANI Pharmaceuticals, Inc.
$59
Organon Llc
$58
Celgene Corporation
$46
Sandoz Inc.
$30
Teva Pharmaceuticals USA, Inc.
$25
SCILEX PHARMACEUTICALS INC.
$25
Celltrion USA Inc.
$25
Fidia Pharma USA Inc.
$24
Hikma Pharmaceuticals USA
$22
Sobi, Inc
$19
Antares Pharma, Inc.
$19
Merck Sharp & Dohme Corporation
$17
Ultragenyx Pharmaceutical Inc.
$17
Top 3 companies account for 71.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DUEXIS · Enbrel · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · OTREXUP · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · XELJANZ · YUFLYMA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for rheumatology in NY.

Looking for a rheumatology specialist in Queensbury?
Compare rheumatologists in the Queensbury area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
6
Per 100K population
9.2
County median income
$78,239
Nearest hospital
GLENS FALLS HOSPITAL
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bryan is a mixed practice specialist, with above-average Medicare volume (top 10% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bryan experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Bryan performed 19,099 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bryan receive payments from pharmaceutical companies?
Yes. Dr. Bryan received a total of $247,441 from 37 companies across 977 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bryan's costs compare to other rheumatologists in Queensbury?
Dr. Bryan's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bryan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →